N4-Acetyl-2'-O-methylcytidine is a chemically modified nucleoside derivative. Its structure features a cytidine base with an acetyl group on the N4 position of the cytosine ring and a methoxy group replacing the hydroxyl group at the 2' position of the ribose sugar. This compound is primarily used as a key intermediate in the synthesis of therapeutic oligonucleotides, particularly in the development of antisense oligonucleotides and small interfering RNAs (siRNAs). The 2'-O-methyl modification enhances the oligonucleotide's stability against nuclease degradation and improves its pharmacokinetic properties, while the N4-acetyl group serves as a protective moiety during solid-phase oligonucleotide synthesis. As a specialized building block for nucleic acid therapeutics, it falls under the category of nucleoside analogs used in medicinal chemistry and life science research. Its application is highly specific to the field of advanced drug development rather than general organic synthesis.